市場調査レポート
商品コード
1386936
研究用抗体市場レポート:2030年までの動向、予測、競合分析Research Antibodies Market Report: Trends, Forecast and Competitive Analysis to 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
研究用抗体市場レポート:2030年までの動向、予測、競合分析 |
出版日: 2023年10月12日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
|
研究用抗体の動向と予測
世界の研究用抗体市場は、2024年から2030年までのCAGRが6.5%で、2030年までに推定55億米ドルに達すると予想されます。この市場の主な促進要因は、多発性硬化症やパーキンソン病の増加による個別化医療の需要の増加、新規薬剤やタンパク質治療薬の開発です。世界の研究用抗体市場の将来は、免疫組織化学、単蛍光、ウェスタンブロッティング、フローサイトメトリー、免疫沈降、ELISAの各市場における機会によって有望視されています。
研究用抗体市場の洞察
Lucintelの予測では、モノクローナル抗体は様々ながんタイプの新しい治療法の発見と開発に使用されており、また、選択性の高い抗体を必要とするがん研究への取り組みが増加していることから、予測期間中、モノクローナル抗体はより大きなセグメントであり続ける。
この市場の中で、免疫組織化学は、酵素、抗原、腫瘍抑制遺伝子、細胞ベースの研究における腫瘍細胞増殖の検出への応用が大きいため、最大のセグメントであり続けると思われます。
北米は、幹細胞、生物医学、がん研究への関心の高まりと、構造ベースのドラッグデザイン開発への投資の増加により、予測期間中最大の地域であり続けると思われます。
Research Antibodies Trends and Forecast
The future of the global research antibodies market looks promising with opportunities in the immunohistochemistry, munofluorescence, western blotting, flow cytometry, immunoprecipitation, and elisa markets. The global research antibodies market is expected to reach an estimated $5.5 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are increasing demand of personalized medicine and the development of novel drugs and protein therapeutics due to the growth in multiple sclerosis and parkinson's disease incidences.
A more than 150-page report is developed to help in your business decisions.
Research Antibodies by Segment
The study includes a forecast for the global research antibodies by product, type, technology, end use, and region.
Research Antibodies Market by Product [Shipment Analysis by Value from 2018 to 2030]:
Research Antibodies Market by Type [Shipment Analysis by Value from 2018 to 2030]:
Research Antibodies Market by Technology [Shipment Analysis by Value from 2018 to 2030]:
Research Antibodies Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
Research Antibodies Market by Region [Shipment Analysis by Value from 2018 to 2030]:
List of Research Antibodies Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies research antibodies companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the research antibodies companies profiled in this report include-
Research Antibodies Market Insights
Lucintel forecasts that monoclonal antibodies will remain the larger segment over the forecast period due to monoclonal antibodies uses in the discovery and development of new treatments for various cancer types and rise in the number of initiatives in cancer research that call for highly selective antibodies..
Within this market, immunohistochemistry will remain the largest segment due to its substantial applications in the detection of enzymes, antigens, tumor suppressor genes, and tumor cell proliferation for cell-based research.
North America will remain the largest region over the forecast period due to the growing focus on stem cells, biomedicine, and cancer research and rising investment in the development of structure-based drug designs in the region.
Features of the Global Research Antibodies Market
Market Size Estimates: Research antibodies market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Research antibodies market size by various segments, such as by product, type, technology, end use, and region in terms of value ($B).
Regional Analysis: Research antibodies market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different products, types, technologies, end uses, and regions for the research antibodies market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the research antibodies market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q.1 What is the research antibodies market size?
Answer: The global research antibodies market is expected to reach an estimated $5.5 billion by 2030.
Q.2 What is the growth forecast for research antibodies market?
Answer: The global research antibodies market is expected to grow with a CAGR of 6.5% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the research antibodies market?
Answer: The major drivers for this market are increasing demand of personalized medicine and the development of novel drugs and protein therapeutics due to the growth in multiple sclerosis and parkinson's disease incidences.
Q4. What are the major segments for research antibodies market?
Answer: The future of the research antibodies market looks promising with opportunities in the immunohistochemistry, munofluorescence, western blotting, flow cytometry, immunoprecipitation, and elisa markets.
Q5. Who are the key research antibodies market companies?
Answer: Some of the key research antibodies companies are as follows:
Q6. Which research antibodies market segment will be the largest in future?
Answer: Lucintel forecasts that monoclonal antibodies will remain the larger segment over the forecast period due to monoclonal antibodies uses in the discovery and development of new treatments for various cancer types and rise in the number of initiatives in cancer research that call for highly selective antibodies..
Q7. In research antibodies market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to the growing focus on stem cells, biomedicine, and cancer research and rising investment in the development of structure-based drug designs in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.